title: Agrypnia excitata: current concepts and future prospects in management.
abstract: Agrypnia excitata is an extremely rare, life-threatening syndrome characterized by autonomic activation, persistent insomnia, and generalized overactivity. Agrypnia excitata describes a triad of three separate conditions: delirium tremens, Morvan's chorea, and familial fatal insomnia (FFI). Each of the aforementioned three conditions have sleep disturbances as a unifying theme and results in distinct neurophysiological findings. The following is an overview of agrypnia excitata with a particular emphasis placed upon each of the three individual conditions that constitute the syndrome with recommendations on appropriate management.
authors.affiliation: Faculty of Arts and Sciences, Harvard University, USA.
authors.forename: Ribhi
authors.initials: R
authors.lastname: Hazin
authors.forename: Jamil Y
authors.initials: JY
authors.lastname: Abuzetun
authors.forename: Pierre
authors.initials: P
authors.lastname: Giglio
authors.forename: Faisal
authors.initials: F
authors.lastname: Khan
mesh_terms: D001342:Autonomic Nervous System Diseases / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D003072:Cognition Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D019468:Disease Management; D005544:Forecasting; D006801:Humans; D034062:Insomnia, Fatal Familial / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D020385:Myokymia / Q000175:diagnosis / Q000523:psychology / Q000628:therapy